Patient Home to acquire pulmonology service provider
2015-01-07 07:07 MT - News Release
Mr. Michael Dalsin reports
PHM ANNOUNCES EXECUTION OF A LETTER OF INTENT (LOI) TO ACQUIRE A REGIONAL BUSINESS IN THE SOUTHEAST WITH $2.25 MILLION IN ANNUALIZED REVENUE; UNTAPPED PATIENT DATABASE FOR CARDIOLOGY SERVICES
Patient Home Monitoring Corp. has executed a non-binding letter of intent to acquire a company reporting unaudited 10-month annualized revenues of approximately $2.25-million and adjusted EBITDA (earnings before interest expense, taxes, depreciation, amortization, stock-based compensation and owner compensation) margins in excess of 20 per cent. This addition to the company's existing Georgia locations makes PHM a dominant provider of home-based health monitoring services in the state.
The acquisition of this growing and profitable company is expected to be immediately accretive to the income statement, and will increase PHM's earnings per share. As a result of this acquisition and the LOI announced on Dec. 22, both expected to close in the first calendar quarter of 2015, PHM's annual revenue run rate is expected to be over $50-million at the time of close.
The business is focused on offering home-based pulmnology services for patients with sleep apnea, oxygen needs and other diseases of the lungs. After the acquisition, PHM expects continued strong organic adjusted EBITDA growth from cross-selling.
According to the LOI, PHM expects to close the acquisition with approximately $1.5-million in cash and approximately 650,000 PHM common shares depending on final due diligence of trailing 12-month adjusted EBITDA. Closing the acquisitions will be subject to final due diligence and a binding purchase agreement.
"With this acquisition, we continue our expansion across the lucrative southeast region of the U.S. market," said Michael Dalsin, chairman of PHM. "While this acquisition is smaller in size, we can use our regional expertise and infrastructure to achieve significant revenue and profit growth through offering cardiology and complex COPD [chronic obstructive pulmonary disease] services. We are targeting this quarter to close this acquisition and the most recently announced LOI in the current quarter. I expect this will have an immediate positive impact on our growth. We have a very full pipeline of potential deals, and we are continuing to grow our M&A [mergers and acquisitions] department. I continue to believe we will close five deals this year, significantly increasing revenues, profits and, most importantly, earnings per share."
We seek Safe Harbor. |
